Yang S, Ye Z, Chen L, Zhou X, Li W, Cheng F
Biomolecules. 2025; 15(1).
PMID: 39858471
PMC: 11762869.
DOI: 10.3390/biom15010077.
Zhang J, Wang Q, Liu J, Duan Y, Liu Z, Zhang Z
Biol Direct. 2024; 19(1):112.
PMID: 39533395
PMC: 11556110.
DOI: 10.1186/s13062-024-00559-x.
Cheng H, Deng H, Ma D, Gao M, Zhou Z, Li H
Heliyon. 2024; 10(20):e39538.
PMID: 39502233
PMC: 11535992.
DOI: 10.1016/j.heliyon.2024.e39538.
Liao H, Wu J, VanDusen N, Li Y, Zheng Y
Mol Ther Nucleic Acids. 2024; 35(4):102344.
PMID: 39494147
PMC: 11531618.
DOI: 10.1016/j.omtn.2024.102344.
Lei X, Huang A, Chen D, Wang X, Ji R, Wang J
Nat Biotechnol. 2024; .
PMID: 39349835
DOI: 10.1038/s41587-024-02394-x.
A pipeline for identifying guide RNA sequences that promote RNA editing of nonsense mutations that cause inherited retinal diseases.
Schneider N, Steinberg R, Ben-David A, Valensi J, David-Kadoch G, Rosenwasser Z
Mol Ther Nucleic Acids. 2024; 35(1):102130.
PMID: 38375504
PMC: 10875612.
DOI: 10.1016/j.omtn.2024.102130.
Game Changing Solutions in Healthcare.
Fahim A, Reza S
Pak J Med Sci. 2024; 40(2ICON Suppl):S3.
PMID: 38328658
PMC: 10844898.
DOI: 10.12669/pjms.40.2(ICON).9128.
A New Era of Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated Protein 9 Gene Editing Technology in Cardiovascular Diseases: Opportunities, Challenges, and Perspectives.
Rahul K, Singh S, Kumar S, Tewarson V, Hakim M, Kaushik K
Heart Views. 2024; 24(4):201-207.
PMID: 38188709
PMC: 10766161.
DOI: 10.4103/heartviews.heartviews_49_23.
Lipid Nanoparticle-Mediated Hit-and-Run Approaches Yield Efficient and Safe Gene Editing in Human Skin.
Bolsoni J, Liu D, Mohabatpour F, Ebner R, Sadhnani G, Tafech B
ACS Nano. 2023; 17(21):22046-22059.
PMID: 37918441
PMC: 10655174.
DOI: 10.1021/acsnano.3c08644.
Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases.
Lu X, Zhang M, Li G, Zhang S, Zhang J, Fu X
Int J Mol Sci. 2023; 24(17).
PMID: 37686009
PMC: 10487642.
DOI: 10.3390/ijms241713202.
Recent Advances in Genome-Engineering Strategies.
Boti M, Athanasopoulou K, Adamopoulos P, Sideris D, Scorilas A
Genes (Basel). 2023; 14(1).
PMID: 36672870
PMC: 9859587.
DOI: 10.3390/genes14010129.
CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
Nasrallah A, Sulpice E, Kobaisi F, Gidrol X, Rachidi W
Cells. 2022; 11(22).
PMID: 36429042
PMC: 9688409.
DOI: 10.3390/cells11223615.
Screening DNA aptamers that control the DNA cleavage, homology-directed repair, and transcriptional regulation of the CRISPR-(d)Cas9 system.
Huang X, Wang M, Wu X, Zou Y, Xu J, Cao C
Mol Ther. 2022; 31(1):260-268.
PMID: 36245127
PMC: 9840146.
DOI: 10.1016/j.ymthe.2022.10.009.
A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases.
Roshanravan N, Tutunchi H, Najafipour F, Dastouri M, Ghaffari S, Jebeli A
J Cardiovasc Thorac Res. 2022; 14(2):77-83.
PMID: 35935390
PMC: 9339732.
DOI: 10.34172/jcvtr.2022.14.
